北京招聘

Position Summary: (需要有BOM经验)
As the finance controller, this role is to monitor and control all finance matters of the plant environment as well as provide sufficient financial data and advice to local leadership team.

Key Activities and Responsibilities:
?Ensure the proper implementation of budget and forecast planning and consolidation of Actuals, as well as performance improvement ;
?Ensure in-time and correct calculate Bill of Materiel for Products. Following the working process, the consumption of materials, production overhead.
?Analyze monthly financial reports on cost and profit, reconcile the difference between planning and actual, make instant adjustment to guarantee target achievement when necessary.
?Performance analysis of inventory control
?Production efficiency analysis,Scrap control by production line potential cost saving proposal
?Cost variance analysis, Usage variance/BOM change/Scrap/Efficiency

Competences, Skills and Qualification:
?Bachelor degree in Finance, Accounting,
?Knowledge of accounting, auditing and controlling standards
?At least 3 years relevant financial experience in production line (working experience in Multinational Corporation , Biological company is preferred)
?Computer knowledge especially with MS Excel,
?Fluent in Mandarin and English both in written and oral
?Self-initiative with solid analytical, good presentation, coordination, communication and interpersonal skills. Teamwork spirit
?Ability to work under pressure.

舒迪安是一家跨国的生物技术公司，致力于开发基于活化树突状细胞的新治疗方法，主要专注癌症和自体免疫性疾病的治疗。我们的使命是采用基于我们自有知识产权的细胞技术并通过我们自有的免疫疗法平台来开发新的治疗产品，为目前人类未得到满足的医疗需求提供世界前沿的拓展治疗手段。一大批世界知名科学家聚集在舒迪安公司总部位于布拉格的研究中心，他们借助于目前最尖端的实验设备积极探索树突状细胞在免疫反应活化治疗中的应用。

舒迪安公司通过下列方式开发最新治疗方法：
采用自体细胞免疫疗法治疗癌症和自体免疫疾病
采用免疫疗法配合化疗等其他标准治疗方式提高临床疗效
研究免疫疗法的长期治疗效果以增强免疫系统对特定疾病的反应能力
使用广谱的肿瘤抗原，通过患者自身树突状细胞的活化，来刺激复杂的免疫反应

舒迪安公司的临床开发方案旨在采用活化树突状细胞免疫疗法，其自体细胞肿瘤免疫治疗产品为某些特定的、现有治疗手段匮乏的部分疾病拓展治疗选择。舒迪安在欧洲和中国北京建设了GMP标准细胞实验室，所生产的基于细胞的医疗产品均符合全球监管标准。

针对不同的癌症（前列腺癌、肺癌、卵巢癌等），舒迪安公司正在开展基于成熟树突状细胞负载免疫原性死亡肿瘤细胞技术的肿瘤免疫疗法的临床应用。多个单病种癌症的临床试验结果验证了舒迪安产品的临床安全性和有效性，显示出了令人振奋的临床治疗效果。

公司地址：北京亦庄经济开发区科创14街汇龙森科技园30号楼B座
市内办公室: 北京朝阳区亮马桥路50号燕莎写字楼C214

Company Introduction
SOTIO is a European biotechnology company developing new therapies based on activated dendritic cells, focusing on the treatment of cancer and autoimmune diseases. Our mission is to develop new medical therapies using our proprietary cell-based technologies to treat highly unmet medical conditions using our immunotherapy platform. Sotio (Beijing), a fast growing subsidiary focusing on China market, is looking for talented, motivated, dynamic employees to join its international team. The company can provide tremendous career development opportunity to its employees.

SOTIO is an Equal Employment Opportunity/Affirmative Action Employer
The policy and practice of SOTIO require that entry into employment and progression within employment will be determined only by personal merit and the application of criteria which are related to the duties of each particular job. Subject to statutory provisions, no applicant or member of staff will be treated less favorably than another because of his or her gender, marital or civil partnership status, sexual orientation, religion or belief, racial group, age or disability. In all cases, ability to perform the job will be the primary consideration.